News and Announcements
WYZA Raises $1.4m, Increases Subscribers to 300,000, Signs New Agreements & Launches New Products
- Published August 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
WYZA is Australia’s fastest growing digital platform created specifically for people 50+. WYZA is disrupting the $200 billion spending patterns of the powerful 50+ demographic by connecting them directly with the products, services and information they want.
- Capital Raised in 2017: $1M and 2018: $425,000
- Grew subscriber database to 300,000
- Liz Walden joined WYZA as GM Insurance
- New Agreements, Reho Travel, WaldenWood Group (Pet Secure) & Zurich
- New products released: Pet and range of Zurich Life Risk products including life, funeral and accidental death
R & D: $200K+ R&D refund:
- Board – Two resignations in last 12 months.
- Board Positions are available.
Conducted extensive review of WYZA platform and developed customer acquisition and audience engagement strategy. This will (when funded) enable to complete the transition to a new content management system.
Integration of a custom data gathering system to dynamically profile audience preferences.
Complete transition to a more sophisticated communication platform to handle email broadcasts and targeted messaging. Integrated membership system which builds an even deeper relationship with audience who join us as members.
Development of persona types to classify our audience in preparation for targeting.
A deep analysis of our existing content library and retrospective tagging to deliver content matches to our personas.
Integration of more sophisticated analytics to ensure we identify issues with the user journey.
ABOUT WYZA LIMITED
Today Australia has over 7.9m people 50+ and this demographic spends $4billion on goods and services each week and holds 40% of Australia’s wealth.WYZA’s growth over the last year has been phenomenal with the WYZA subscriber base increasing over 100% in the last 12 months.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
